Skip to main content

Table 1 Characteristics of the gastric cancer patient tumour samples analyzed for drug sensitivity

From: Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy

Sex Age at tumour sampling Stage at tumour sampling* Histology Prior chemotherapy
Male 39 Metastatic Signet-ring cell Yes
Female 58 Metastatic Signet-ring cell Yes
Male 60 Metastatic Intestinal Yes
Male 58 Localized Diffuse Yes
Female 71 Localized Diffuse Yes
Female 54 Metastatic Signet-ring cell Yes
Male 66 Localized Intestinal No
Male 75 Localized Intestinal Yes
Female 67 Metastatic Diffuse Yes
Male 74 Localized Intestinal Yes
Female 70 Localized Intestinal No
Male 70 Localized Intestinal Yes
Male 70 Localized Intestinal Yes
Female 61 Localized Intestinal No
Female 88 Localized Intestinal No
Male 74 Localized Intestinal Yes
  1. *Patients with localized disease underwent curative surgery and tumour sampling was from the primary tumour. Patients with metastatic disease had carcinosis, were planned for cytoreductive surgery and intraperitoneal chemotherapy and tumour sampling was from carcinosis.